These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 12568314)

  • 1. Inhibition of CD4 expression by antisense oligonucleotides in PMA-treated lymphocytes.
    Rabanal M; Franch A; Noé V; Ciudad CJ; Castell M; Castellote C
    Antisense Nucleic Acid Drug Dev; 2002 Dec; 12(6):399-410. PubMed ID: 12568314
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD4 expression decrease by antisense oligonucleotides: inhibition of rat T CD4+ cell reactivity.
    Rabanal M; Franch A; Noé V; Pelegrí C; Ciudad CJ; Castellote C; Castell M
    Oligonucleotides; 2003; 13(4):217-28. PubMed ID: 15000837
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An antisense oligodeoxynucleotide to growth hormone messenger ribonucleic acid inhibits lymphocyte proliferation.
    Weigent DA; Blalock JE; LeBoeuf RD
    Endocrinology; 1991 Apr; 128(4):2053-7. PubMed ID: 2004616
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Inhibition of hepatitis C virus by antisense oligodeoxynucleotide in vitro].
    Liu Y; Chen Z; He N
    Zhonghua Yi Xue Za Zhi; 1997 Aug; 77(8):567-70. PubMed ID: 9772458
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of multidrug resistance in human leukemia cells with mdr1-targeted antisense oligonucleotides using variable treatment schedules.
    Dassow H; Lassner D; Remke H; Preiss R
    Int J Clin Pharmacol Ther; 2000 Apr; 38(4):209-16. PubMed ID: 10783831
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of N-methyl-D-aspartate glutamate receptor subunit expression by antisense oligonucleotides reveals their role in striatal motor regulation.
    Standaert DG; Testa CM; Rudolf GD; Hollingsworth ZR
    J Pharmacol Exp Ther; 1996 Jan; 276(1):342-52. PubMed ID: 8558453
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Messenger RNA expression profiling of genes involved in epidermal growth factor receptor signalling in human cancer cells treated with scanning array-designed antisense oligonucleotides.
    Petch AK; Sohail M; Hughes MD; Benter I; Darling J; Southern EM; Akhtar S
    Biochem Pharmacol; 2003 Sep; 66(5):819-30. PubMed ID: 12948863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cationic lipids reduce time and dose of c-myc antisense oligodeoxynucleotides required to specifically inhibit Burkitt's lymphoma cell growth.
    Williams SA; Chang L; Buzby JS; Suen Y; Cairo MS
    Leukemia; 1996 Dec; 10(12):1980-9. PubMed ID: 8946941
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antisense oligodeoxynucleotides for in vivo targeting of corticotropin-releasing hormone mRNA: comparison of phosphorothioate and 3'-inverted probe performance.
    Skutella T; Stöhr T; Probst JC; Ramalho-Ortigao FJ; Holsboer F; Jirikowski GF
    Horm Metab Res; 1994 Oct; 26(10):460-4. PubMed ID: 7851868
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phorbol esters down-regulate transcription and translation of the CD4 gene.
    Neudorf S; Jones M; Parker S; Papes R; Lattier D
    J Immunol; 1991 Apr; 146(8):2836-40. PubMed ID: 1707923
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polyethylenimine but not cationic lipid improves antisense activity of 3'-capped phosphodiester oligonucleotides.
    Dheur S; Dias N; van Aerschot A; Herdewijn P; Bettinger T; Rémy JS; Hélène C; Saison-Behmoaras ET
    Antisense Nucleic Acid Drug Dev; 1999 Dec; 9(6):515-25. PubMed ID: 10645777
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduction of erbB2 gene product in mamma carcinoma cell lines by erbB2 mRNA-specific and tyrosine kinase consensus phosphorothioate antisense oligonucleotides.
    Bertram J; Killian M; Brysch W; Schlingensiepen KH; Kneba M
    Biochem Biophys Res Commun; 1994 Apr; 200(1):661-7. PubMed ID: 7909438
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sequence-specific inhibition of gene expression in intact human skin by epicutaneous application of chimeric antisense oligodeoxynucleotides.
    Wingens M; Pfundt R; van Vlijmen-Willems IM; van Hooijdonk CA; van Erp PE; Schalkwijk J
    Lab Invest; 1999 Nov; 79(11):1415-24. PubMed ID: 10576212
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is antisense an appropriate nomenclature or design for oligodeoxynucleotides aimed at the inhibition of HIV-1 replication?
    Lavigne C; Yelle J; Sauve G; Thierry AR
    AAPS PharmSci; 2002; 4(2):E9. PubMed ID: 12102618
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differentiation intensifies the susceptibility of pheochromocytoma cells to antisense oligodeoxynucleotide-dependent suppression of acetylcholinesterase activity.
    Grifman M; Soreq H
    Antisense Nucleic Acid Drug Dev; 1997 Aug; 7(4):351-9. PubMed ID: 9303187
    [TBL] [Abstract][Full Text] [Related]  

  • 16. VP22 light controlled delivery of oligonucleotides to ocular cells in vitro and in vivo.
    Normand N; Valamanesh F; Savoldelli M; Mascarelli F; BenEzra D; Courtois Y; Behar-Cohen F
    Mol Vis; 2005 Mar; 11():184-91. PubMed ID: 15761390
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Specific regulation of gene expression in brain by antisense oligodeoxynucleotides].
    Yoshikawa M; Oka T
    Nihon Yakurigaku Zasshi; 1997 Apr; 109(4):187-91. PubMed ID: 9160348
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Specific inhibition of hepatitis C viral gene expression by antisense phosphorothioate oligodeoxynucleotides.
    Alt M; Renz R; Hofschneider PH; Paumgartner G; Caselmann WH
    Hepatology; 1995 Sep; 22(3):707-17. PubMed ID: 7657273
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hairpin extensions enhance the efficacy of mycolyl transferase-specific antisense oligonucleotides targeting Mycobacterium tuberculosis.
    Harth G; Zamecnik PC; Tabatadze D; Pierson K; Horwitz MA
    Proc Natl Acad Sci U S A; 2007 Apr; 104(17):7199-204. PubMed ID: 17438292
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Requirements for modulation of the CD4 molecule in response to phorbol myristate acetate. Role of the cytoplasmic domain.
    Sleckman BP; Bigby M; Greenstein JL; Burakoff SJ; Sy MS
    J Immunol; 1989 Mar; 142(5):1457-62. PubMed ID: 2783943
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.